RecruitingNot ApplicableNCT07196150

Exercise, Motor Imagery, and Pain Neuroscience Education for Primary Dysmenorrhea: A Randomized Trial

Comparison of the Effects of Exercise, Motor Imagery Training, and Pain Neuroscience Education on Pain, Menstrual Symptoms, and Cognitive Flexibility in Women With Primary Dysmenorrhea: A Randomized Controlled Trial


Sponsor

Muge Dereli

Enrollment

51 participants

Start Date

Feb 25, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to find out whether exercise, motor imagery training, and pain neuroscience education can help reduce menstrual pain and improve well-being in young women with primary dysmenorrhea. The study will also look at how these approaches affect menstrual symptoms, movement control, and cognitive flexibility. The main questions it aims to answer are: * Does adding motor imagery or pain neuroscience education to an exercise program reduce pain and menstrual symptoms more than exercise alone? * Do these approaches improve movement control, thinking flexibility, and knowledge about pain? Researchers will compare three groups: * Exercise only * Exercise plus motor imagery training * Exercise plus pain neuroscience education Participants will: * Attend supervised exercise sessions twice a week for 8 weeks * Practice either motor imagery or receive short pain neuroscience education, depending on their group * Complete questionnaires and tests before and after the program, during the first three days of menstruation


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 25 Years

Inclusion Criteria7

  • Female, aged 18-25 years
  • Gynecological examination and ultrasound confirming absence of pelvic pathology
  • History of primary dysmenorrhea for at least 6 months, with pain intensity ≥4 on the Numeric Rating Scale (0-10) during the first 3 days of menstruation
  • Regular menstrual cycles (21-35 days)
  • Nulliparous (no history of pregnancy or childbirth)
  • No systemic, metabolic, rheumatologic, or lumbar pathology
  • Willingness to participate in the 8-week intervention program and attend follow-up assessments

Exclusion Criteria9

  • Diagnosis of secondary dysmenorrhea (e.g., endometriosis, pelvic inflammatory disease, uterine fibroids, ovarian cysts)
  • Current pregnancy or planning to become pregnant during the study period
  • History of pelvic or abdominal surgery
  • History of sexually transmitted diseases
  • Current use of antidepressants, anxiolytics, or hormonal therapy (e.g., oral contraceptives, intrauterine device)
  • Known neurological, psychiatric, or systemic musculoskeletal disorders
  • Cognitive impairment or attention deficit that may interfere with participation
  • Participation in regular exercise in the last 6 months
  • Use of alternative therapies for dysmenorrhea (e.g., acupuncture, massage)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALExercise Program

Participants will complete an 8-week supervised exercise program, delivered twice per week. The program includes lumbopelvic stabilization, stretching, and endurance training exercises designed to reduce menstrual pain and improve physical function.

BEHAVIORALExercise plus Motor Imagery Training

Participants will complete the same 8-week supervised exercise program as the Exercise Only group. In addition, they will practice kinesthetic motor imagery of the prescribed movements prior to performing them, aiming to enhance motor control and pain modulation.

BEHAVIORALExercise plus Pain Neuroscience Education

Participants will complete the same 8-week supervised exercise program as the Exercise Only group. In addition, they will receive weekly face-to-face pain neuroscience education sessions focused on pain neurophysiology, supported with home assignments to reinforce learning.


Locations(1)

Aydın Adnan Menderes University

Aydin, Efeler, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07196150


Related Trials